Search

everythinglearnresearchcommunity

for

Search:↓

Young women in West Bengal, India, with PCOS often have estrogen resistance, leptin receptor issues, folate deficiency, T2DM, and acanthosis, commonly linked to obesity.

Erlotinib causes skin inflammation through IL-1, which can be reduced by anakinra.

Topical aprepitant reduces skin rash and hair loss caused by cancer treatment.

Understanding EGFR roles could lead to new hair loss treatments.

Manipulating EGFR signaling may help treat hair loss and promote hair growth.

TGF-alpha affects skin thickness, hair growth, and may contribute to psoriasis and papilloma formation.

EGFR signaling is crucial for skin and hair health, and targeting it could help treat skin diseases and cancer.

Keratin 16 delays skin maturation and affects skin and hair development in mice.

A cancer patient died from a severe skin reaction after taking the drug cetuximab.

Overexpressing the epigen gene in mice leads to enlarged sebaceous glands and greasy fur.

Erlotinib can cause hair loss as a side effect.

Reducing gefitinib dosage improved hair loss, but scarring remained.

New chemotherapy drugs cause skin side effects, but treatments like minocycline and tetracycline can help reduce them.

Targeted cancer therapies can cause skin side effects, which should be treated early to help patients' quality of life and treatment adherence.

Activating Nrf2 in skin cells speeds up wound healing by increasing the growth of certain stem cells.

Sema3A can both slow and speed up wound healing, depending on its form and combination with EGF.

A cancer drug caused unusual hair growth on a 100-year-old man's scalp and eyelashes.

Skin's epithelial stem cells are crucial for repair and maintenance, and understanding them could improve treatments for skin problems.

Erlotinib can cause significant but temporary hair loss in lung cancer patients.

Skin side effects from cancer treatments can lead to changes in therapy and are common, with nail changes being the most frequent.

GLI1 might protect against the start of skin cancer and is not linked to cancer severity.

Some drugs, especially biologics, can cause skin reactions that look like other skin diseases, and stopping the drug usually helps clear up these reactions.

Piperonylic acid speeds up wound healing by reducing inflammation and boosting collagen.

Some vitamin D analogs can thicken skin and reduce pore size like a common acne treatment, with one analog also affecting skin growth factors.

Chemotherapy and radiotherapy can cause skin side effects like rashes, hair loss, and nail changes, which are usually managed with conservative treatments.

A man's severe skin reaction from cancer treatment improved with early diagnosis and proper medication.

New cancer treatments are less harmful to hair but can still cause hair loss, color, shape, and growth changes.

Combining ficlatuzumab and gefitinib can cause severe scarring hair loss.

Tyrosine kinase inhibitors for endocrine tumors often cause skin issues, requiring early management and treatment adjustments.

Chemotherapy often causes skin and hair issues, but early management can help improve patient care.